Business, energy, technology, markets and global industry news from Business News Today

MK-8748

PharmaDeviceNews MK-8748
Ingenia Therapeutics’ dual Prix Galien USA and Korea nominations add visibility to the newly listed biotech as attention turns to its TIE2-based vascular therapeutics pipeline, including MK-8748 and IGT-303. Representative image.
Pharma & Biotech

Ingenia Therapeutics has two Prix Galien nominations, but its real test begins after the KOSDAQ IPO

Ingenia Therapeutics gains dual Prix Galien nominations as its KOSDAQ debut puts MK-8748, IGT-303 and the broader TIE2 pipeline under scrutiny.

Read More